A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT02158936 · TERMINATED
Trial details
- NCT number
- NCT02158936
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-10
- Primary completion
- 2016-04-30
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.